You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CHOP Chemotherapy protocol

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diffuse Large B-cell Lymphoma (DLBCL) Trial in Westbury (Odronextamab, Rituximab, Cyclophosphamide)

Recruiting
  • Diffuse Large B-cell Lymphoma (DLBCL)
  • Westbury, New York
    Clinical Research Alliance Inc
Oct 13, 2023

Diffuse Large B-cell Lymphoma Trial in Shanghai (Rituximab, Cyclophosphamide, Epirubicin)

Active, not recruiting
  • Diffuse Large B-cell Lymphoma
  • Shanghai, Shanghai, China
    Shanghai Ruijin Hospital
Dec 1, 2022

Advanced DLBCL, Extra-nodal Involvement, Large Mass, Radiotherapy Trial (6-8 cycles (21 days per cycle) of Standard R-CHOP

Not yet recruiting
  • Advanced Diffuse Large B-Cell Lymphoma
  • +2 more
  • 6-8 cycles (21 days per cycle) of Standard R-CHOP chemotherapy
  • Radiotherapy beyond standard R-CHOP Chemotherapy
  • (no location specified)
May 24, 2023

Diffuse Large B Cell Lymphoma Trial in Busan (PrednisoLONE 50 MG)

Completed
  • Diffuse Large B Cell Lymphoma
  • PrednisoLONE 50 MG
  • Busan, Sue-gu, Korea, Republic of
    Kosin University Gospel Hospital
Mar 31, 2022

T-cell Lymphoma Trial (CHOP + CD4, CHOP)

Terminated
Has Results
  • T-cell Lymphoma
  • (no location specified)
May 2, 2022

EBV-Positive DLBCL, Nos Trial in Guangzhou, Shanghai (Selinexor, R-CHOP Protocol)

Recruiting
  • EBV-Positive Diffuse Large B-Cell Lymphoma, Nos
  • Guangzhou, Guangdong, China
  • +1 more
Nov 10, 2022

Mantle Cell Lymphoma Trial in Canada (Acalabrutinib, R-CHOP chemo)

Recruiting
  • Mantle Cell Lymphoma
  • Vancouver, British Columbia, Canada
  • +3 more
Mar 17, 2022

Lymphoma, Large B-Cell, Diffuse Trial in Austria, Germany (Glofitamab, Rituximab, Obinutuzumab)

Not yet recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • Linz, Austria
  • +17 more
Mar 22, 2023

Mucositis Oral Trial in Izmir (oral self care protocol, standard care)

Completed
  • Mucositis Oral
  • oral self care protocol
  • standard care
  • İzmir, Bornova, Turkey
    Ege University Medical Faculty Hospital
Sep 21, 2023

Posttransplant Lymphoproliferative Disorder Trial in Germany (Rituximab sc, Rituximab sc consolidation, Rituximab sc combined

Completed
  • Posttransplant Lymphoproliferative Disorder
  • Rituximab sc
  • +3 more
  • Aachen, Germany
  • +17 more
Aug 22, 2022

Diffuse Large B Cell Lymphoma Trial in Rouen (Measure of the circulating tumor DNA)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • Measure of the circulating tumor DNA
  • Rouen, France
    Centre Henri Becquerel
Nov 17, 2023

Immune Deficiency, Diet, Healthy, Breast Cancer Trial in Cairo (Aerobic exercises, Diet protocol)

Recruiting
  • Immune Deficiency
  • +2 more
  • Aerobic exercises
  • Diet protocol
  • Cairo, New Cairo, Egypt
    Shaimaa Mohamed Ahmed Elsayeh
Nov 3, 2022

Malignant Peritoneal Mesothelioma, Peritoneal Mesothelioma, Mesothelioma Trial in United States (Pemetrexed, Cisplatin,

Recruiting
  • Malignant Peritoneal Mesothelioma
  • +4 more
  • Chicago, Illinois
  • +10 more
Sep 21, 2023

Diffuse Large B-cell Lymphoma, HIV Trial in Lilongwe (R-CHOP)

Active, not recruiting
  • Diffuse Large B-cell Lymphoma
  • HIV
  • Lilongwe, Malawi
    UNC Project, Lighthouse Trust
Oct 18, 2021

Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Follicular Lymphoma Grade IIIb Trial in Guangzhou (Toripalimab,

Recruiting
  • Diffuse Large B Cell Lymphoma
  • +5 more
  • Toripalimab, Rituximab
  • R-CHOP Protocol
  • Guangzhou, Guangdong, China
    Department of hematology department, Nanfang hospital
Apr 6, 2022

AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell

Completed
Has Results
  • AIDS-related Diffuse Large Cell Lymphoma
  • +8 more
  • Eldoret, Kenya
  • +1 more
Sep 12, 2022

Solid Tumor, Childhood Trial (Chemotherapy involving cisplatin or carboplatin)

Not yet recruiting
  • Solid Tumor, Childhood
  • Chemotherapy involving cisplatin or carboplatin
  • (no location specified)
Nov 21, 2022

Multidisciplinary Care Program to Secure mEdication Therapy for

Not yet recruiting
  • Chemotherapy Effect
  • +2 more
  • Assessment of patient satisfaction regarding tele-consultation
  • +4 more
  • Pierre-Bénite, France
    Hôpital Lyon Sud - Hospices Civils de lyon
Apr 22, 2022

Chemo-induced Peripheral Neuropathy, Nerve Pain Trial in United States (Electroacupuncture, Sham Acupuncture)

Recruiting
  • Chemotherapy-induced Peripheral Neuropathy
  • Nerve Pain
  • Electroacupuncture
  • Sham Acupuncture
  • Basking Ridge, New Jersey
  • +4 more
Jan 19, 2023

Esophageal Cancer, Gastric Adenocarcinoma, HER2 Gene Mutation Trial in United States (Pembrolizumab, Trastuzumab)

Not yet recruiting
  • Esophageal Cancer
  • +2 more
  • Baltimore, Maryland
  • +8 more
Nov 3, 2023

Chemo-Induced Peripheral Neuropathy Trial in United States (Yoga, Education control, Usual care)

Recruiting
  • Chemotherapy-Induced Peripheral Neuropathy
  • Yoga
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Dec 5, 2022

High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements, High Grade B-Cell Lymphoma, Not Otherwise Specified,

Recruiting
  • High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements
  • +4 more
  • Orelabrutinib+R-CHOP; Orelabrutinib+R-DA-EPOCH; Orelabrutinib+R-HD MTX;Orelabrutinib+R+other chemotherapies
  • Jinan, Shandong, China
    Shandong Provincial Hospital
Nov 18, 2021

Follicular Lymphoma (FL) Trial (biological, drug, other)

Not yet recruiting
  • Follicular Lymphoma (FL)
  • Tisagenlecleucel
  • +4 more
  • (no location specified)
May 24, 2023

DLBCL, Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma Trial in Seattle (procedure, drug, biological)

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma
  • +2 more
  • Biopsy
  • +7 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 12, 2022

High Grade B-Cell Lymphoma, Not Otherwise Specified, High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements,

Recruiting
  • High Grade B-Cell Lymphoma, Not Otherwise Specified
  • +4 more
  • Zanubrutinib+R-CHOP; Zanubrutinib+R-DA-EPOCH; Zanubrutinib+R-HD MTX
  • R-CHOP; R-DA-EPOCH; R-HD MTX
  • Jinan, Shandong, China
    Department of Hematology, Shandong Provincial Hospital
Dec 7, 2021